Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biotechnology Business
Paris Court Will Rule on the Distribution Rights for Gilead Products in Switzerland
November 9th, 2007
TRB CHEMEDICA INTERNATIONAL S.A. has issued legal proceedings against Gilead Science Limited in a dispute over the distribution rights of their products Viread(TM), Hepsera(TM), Truvada(TM) and Emtriva(TM) for Switzerland. TRB CHEMEDICA INTERNATIONAL, a small, family-owned Swiss pharmaceutical company based in Geneva, was granted exclusive rights by GILEAD in 2003 to hold the regulatory approvals with related reimbursements and to distribute their products in Switzerland. Through substantial investment in scientific support and promotion and an efficient distribution structure, TRB CHEMEDICA INTERNATIONAL achieved sales of SFr. 25 million in...
Source: Biotech Law Weekly (2007-11-09)
|
